J Pfeilschifter

Author PubWeight™ 181.88‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Cyclooxygenase-independent actions of cyclooxygenase inhibitors. FASEB J 2001 2.52
2 Large and sustained induction of chemokines during impaired wound healing in the genetically diabetic mouse: prolonged persistence of neutrophils and macrophages during the late phase of repair. J Invest Dermatol 2000 2.42
3 Modulation of type beta transforming growth factor activity in bone cultures by osteotropic hormones. Proc Natl Acad Sci U S A 1987 2.29
4 The Global Longitudinal Study of Osteoporosis in Women (GLOW): rationale and study design. Osteoporos Int 2009 1.85
5 Physiology and pathophysiology of sphingolipid metabolism and signaling. Biochim Biophys Acta 2000 1.77
6 Counterregulation of interleukin-18 mRNA and protein expression during cutaneous wound repair in mice. J Invest Dermatol 1999 1.58
7 Leptin enhances wound re-epithelialization and constitutes a direct function of leptin in skin repair. J Clin Invest 2000 1.45
8 Effects of transforming growth factor-beta on osteoblastic osteosarcoma cells. Endocrinology 1987 1.42
9 Serum interleukin 6 is a major predictor of bone loss in women specific to the first decade past menopause. J Clin Endocrinol Metab 2001 1.42
10 [The prevention of osteoporosis]. Dtsch Med Wochenschr 2001 1.39
11 Ceramide-binding and activation defines protein kinase c-Raf as a ceramide-activated protein kinase. Proc Natl Acad Sci U S A 1996 1.34
12 Two distinct signaling pathways trigger the expression of inducible nitric oxide synthase in rat renal mesangial cells. Proc Natl Acad Sci U S A 1994 1.33
13 Hypoxia induces macrophage inflammatory protein-2 (MIP-2) gene expression in murine macrophages via NF-kappaB: the prominent role of p42/ p44 and PI3 kinase pathways. FASEB J 2004 1.31
14 Amplification of IL-1 beta-induced matrix metalloproteinase-9 expression by superoxide in rat glomerular mesangial cells is mediated by increased activities of NF-kappa B and activating protein-1 and involves activation of the mitogen-activated protein kinase pathways. J Immunol 2000 1.30
15 The function of nitric oxide in wound repair: inhibition of inducible nitric oxide-synthase severely impairs wound reepithelialization. J Invest Dermatol 1999 1.29
16 Atrial natriuretic peptide inhibits renin release from juxtaglomerular cells by a cGMP-mediated process. Proc Natl Acad Sci U S A 1986 1.25
17 Transforming growth factor beta inhibits formation of osteoclast-like cells in long-term human marrow cultures. Proc Natl Acad Sci U S A 1988 1.20
18 Failure to perceive increased risk of fracture in women 55 years and older: the Global Longitudinal Study of Osteoporosis in Women (GLOW). Osteoporos Int 2010 1.19
19 Expression and release of IL-18 binding protein in response to IFN-gamma. J Immunol 2001 1.19
20 Nitric oxide triggers enhanced induction of vascular endothelial growth factor expression in cultured keratinocytes (HaCaT) and during cutaneous wound repair. FASEB J 1999 1.16
21 Molecular mechanisms of inducible nitric oxide synthase gene expression by IL-1beta and cAMP in rat mesangial cells. J Immunol 1998 1.14
22 Pertussis toxin abolishes angiotensin II-induced phosphoinositide hydrolysis and prostaglandin synthesis in rat renal mesangial cells. Biochem J 1986 1.14
23 Role of phospholipase C and protein kinase C in vasoconstrictor-induced prostaglandin synthesis in cultured rat renal mesangial cells. Biochem J 1986 1.13
24 Activation of phospholipase C and prostaglandin synthesis by [arginine]vasopressin in cultures. Biochem J 1984 1.12
25 Molecular mechanisms of dexamethasone inhibition of nitric oxide synthase expression in interleukin 1 beta-stimulated mesangial cells: evidence for the involvement of transcriptional and posttranscriptional regulation. Proc Natl Acad Sci U S A 1996 1.11
26 Expressional regulation of angiopoietin-1 and -2 and the tie-1 and -2 receptor tyrosine kinases during cutaneous wound healing: a comparative study of normal and impaired repair. Lab Invest 2001 1.11
27 Stimulation by extracellular ATP and UTP of the mitogen-activated protein kinase cascade and proliferation of rat renal mesangial cells. Br J Pharmacol 1994 1.10
28 Upregulation of group IB secreted phospholipase A(2) and its M-type receptor in rat ANTI-THY-1 glomerulonephritis. Kidney Int 2006 1.10
29 Serum bone sialoprotein in patients with primary breast cancer is a prognostic marker for subsequent bone metastasis. Clin Cancer Res 1999 1.10
30 Activation of protein kinase C subtypes alpha, gamma, delta, epsilon, zeta, and eta by tumor-promoting and nontumor-promoting agents. Biochem Pharmacol 1997 1.09
31 Platelet-derived growth factor and angiotensin II stimulate the mitogen-activated protein kinase cascade in renal mesangial cells: comparison of hypertrophic and hyperplastic agonists. Biochem J 1995 1.09
32 Decorin deficiency in diabetic mice: aggravation of nephropathy due to overexpression of profibrotic factors, enhanced apoptosis and mononuclear cell infiltration. J Physiol Pharmacol 2009 1.08
33 Burden of non-hip, non-vertebral fractures on quality of life in postmenopausal women: the Global Longitudinal study of Osteoporosis in Women (GLOW). Osteoporos Int 2012 1.07
34 Tumour promotor 12-O-tetradecanoylphorbol 13-acetate inhibits angiotensin II-induced inositol phosphate production and cytosolic Ca2+ rise in rat renal mesangial cells. FEBS Lett 1986 1.07
35 Inducible NO synthase: role in cellular signalling. J Exp Biol 1999 1.06
36 Anti-inflammatory effects of sevoflurane and mild hypothermia in endotoxemic rats. Acta Anaesthesiol Scand 2007 1.06
37 Interferon-gamma mediates gene expression of IL-18 binding protein in nonleukocytic cells. Biochem Biophys Res Commun 2000 1.06
38 Selective inhibition of cyclooxygenase 2. Biochem Pharmacol 1994 1.06
39 Ceramide binds to the CaLB domain of cytosolic phospholipase A2 and facilitates its membrane docking and arachidonic acid release. FASEB J 2000 1.05
40 Role of protein kinase C in inhibition of renin release caused by vasoconstrictors. Am J Physiol 1986 1.04
41 Possible regulatory functions of protein kinase C-alpha and -epsilon isoenzymes in rat renal mesangial cells. Stimulation of prostaglandin synthesis and feedback inhibition of angiotensin II-stimulated phosphoinositide hydrolysis. Biochem J 1991 1.03
42 Selective ceramide binding to protein kinase C-alpha and -delta isoenzymes in renal mesangial cells. Biochemistry 1998 1.02
43 Interleukin-1beta induces chronic activation and de novo synthesis of neutral ceramidase in renal mesangial cells. J Biol Chem 2001 1.01
44 Nitric oxide donors induce stress signaling via ceramide formation in rat renal mesangial cells. J Biol Chem 1999 1.01
45 Interleukin-1 beta- and forskolin-induced synthesis and secretion of group II phospholipase A2 and prostaglandin E2 in rat mesangial cells is prevented by transforming growth factor-beta 2. J Biol Chem 1992 1.00
46 Disease-specific perception of fracture risk and incident fracture rates: GLOW cohort study. Osteoporos Int 2013 1.00
47 Interleukin-1 beta, tumor necrosis factor and forskolin stimulate the synthesis and secretion of group II phospholipase A2 in rat mesangial cells. Biochem Biophys Res Commun 1991 1.00
48 Hypoxia and cobalt stimulate lactate dehydrogenase (LDH) activity in vascular smooth muscle cells. Pflugers Arch 1994 1.00
49 Effect of extracellular ATP on contraction, cytosolic calcium activity, membrane voltage and ion currents of rat mesangial cells in primary culture. Br J Pharmacol 1993 1.00
50 Large induction of the chemotactic cytokine RANTES during cutaneous wound repair: a regulatory role for nitric oxide in keratinocyte-derived RANTES expression. Biochem J 2000 1.00
51 Nitric oxide induces MIP-2 transcription in rat renal mesangial cells and in a rat model of glomerulonephritis. FASEB J 2001 1.00
52 Protein kinase C phosphorylates and activates GTP cyclohydrolase I in rat renal mesangial cells. Biochem Biophys Res Commun 1998 1.00
53 Glucocorticoids inhibit lipopolysaccharide-induced up-regulation of arginase in rat alveolar macrophages. Br J Pharmacol 2001 0.99
54 A novel keratinocyte mitogen: regulation of leptin and its functional receptor in skin repair. J Invest Dermatol 2001 0.99
55 Mechanisms of suppression of inducible nitric-oxide synthase (iNOS) expression in interferon (IFN)-gamma-stimulated RAW 264.7 cells by dexamethasone. Evidence for glucocorticoid-induced degradation of iNOS protein by calpain as a key step in post-transcriptional regulation. J Biol Chem 1997 0.99
56 Tumor necrosis factor-alpha and lipopolysaccharide induce apoptotic cell death in bovine glomerular endothelial cells. Kidney Int 1999 0.98
57 Lipoteichoic acid induces delayed protection in the rat heart: A comparison with endotoxin. Arterioscler Thromb Vasc Biol 2000 0.98
58 Pyrrolidine dithiocarbamate differentially affects interleukin 1 beta- and cAMP-induced nitric oxide synthase expression in rat renal mesangial cells. Biochem Biophys Res Commun 1994 0.97
59 Stimulation by extracellular ATP and UTP of the stress-activated protein kinase cascade in rat renal mesangial cells. Br J Pharmacol 1997 0.96
60 Decline in the expression of copper/zinc superoxide dismutase in the kidney of rats with endotoxic shock: effects of the superoxide anion radical scavenger, tempol, on organ injury. Br J Pharmacol 1998 0.96
61 Nitric oxide donors induce apoptosis in glomerular mesangial cells, epithelial cells and endothelial cells. Eur J Pharmacol 1996 0.96
62 Increased cytokine secretion by human bone marrow cells after menopause or discontinuation of estrogen replacement. J Clin Endocrinol Metab 1995 0.96
63 Fear of falling, fracture history, and comorbidities are associated with health-related quality of life among European and US women with osteoporosis in a large international study. Osteoporos Int 2013 0.95
64 Identification of copper/zinc superoxide dismutase as a nitric oxide-regulated gene in human (HaCaT) keratinocytes: implications for keratinocyte proliferation. Biochem J 2000 0.95
65 Immunocharacterization of delta- and zeta-isoenzymes of protein kinase C in rat renal mesangial cells. FEBS Lett 1992 0.95
66 Expression of nitric oxide synthase in rat glomerular mesangial cells mediated by cyclic AMP. Br J Pharmacol 1994 0.95
67 Interleukin-1 beta and transforming growth factor-beta 2 enhance cytosolic high-molecular-mass phospholipase A2 activity and induce prostaglandin E2 formation in rat mesangial cells. Eur J Biochem 1992 0.95
68 Nitric oxide modulates expression of matrix metalloproteinase-9 in rat mesangial cells. Kidney Int 2000 0.95
69 Association of transforming growth factor-beta1 (TGFbeta1) T29 --> C gene polymorphism with bone mineral density (BMD), changes in BMD, and serum concentrations of TGF-beta1 in a population-based sample of postmenopausal german women. Calcif Tissue Int 2001 0.95
70 Is renin secretion governed by the calcium permeability of the juxtaglomerular cell membrane? Biochem Biophys Res Commun 1984 0.94
71 Macrophage-derived heme-oxygenase-1: expression, regulation, and possible functions in skin repair. Mol Med 2001 0.94
72 Amplification of nitric oxide synthase expression by nitric oxide in interleukin 1 beta-stimulated rat mesangial cells. J Clin Invest 1995 0.94
73 Molecular cloning of the rat inducible nitric oxide synthase gene promoter. Biochem Biophys Res Commun 1996 0.92
74 Differential regulation of vascular endothelial growth factor and its receptor fms-like-tyrosine kinase is mediated by nitric oxide in rat renal mesangial cells. Biochem J 1999 0.92
75 The balance between nitric oxide and superoxide determines apoptotic and necrotic death of rat mesangial cells. J Immunol 1997 0.92
76 [Diagnosis and treatment of postmenopausal osteoporosis and osteoporosis in men. German Guidelines Update 2006]. Orthopade 2007 0.92
77 Concentration of insulin-like growth factor (IGF)-I and -II in iliac crest bone matrix from pre- and postmenopausal women: relationship to age, menopause, bone turnover, bone volume, and circulating IGFs. J Clin Endocrinol Metab 1998 0.92
78 Cyclosporin derivatives inhibit interleukin 1 beta induction of nitric oxide synthase in renal mesangial cells. Eur J Pharmacol 1993 0.92
79 IL-18 is expressed in the intercalated cell of human kidney. Kidney Int 2007 0.92
80 Nitric oxide stimulates the stress-activated protein kinase p38 in rat renal mesangial cells. J Exp Biol 1999 0.91
81 New insights into the mechanism for clearance of apoptotic cells. Bioessays 2000 0.91
82 Cellular mechanisms of ATP-induced hyperpolarization in renal epitheloid MDCK-cells. J Cell Physiol 1991 0.90
83 Extracellular nucleotides induce migration of renal mesangial cells by upregulating sphingosine kinase-1 expression and activity. Br J Pharmacol 2007 0.89
84 Extracellular nucleotides activate the p38-stress-activated protein kinase cascade in glomerular mesangial cells. Br J Pharmacol 2000 0.89
85 Immunocharacterization of protein kinase C isoenzymes in rat kidney glomeruli, and cultured glomerular epithelial and mesangial cells. Exp Nephrol 1994 0.89
86 Dexamethasone inhibits TNF-alpha-induced apoptosis and IAP protein downregulation in MCF-7 cells. Br J Pharmacol 2001 0.89
87 Transforming growth factor beta (TGF-beta) levels in the conditioned media of human bone cells: relationship to donor age, bone volume, and concentration of TGF-beta in human bone matrix in vivo. Bone 1999 0.89
88 Lack of interferon-gamma production despite the presence of interleukin-18 during cutaneous wound healing. Mol Med 2000 0.88
89 Dexamethasone suppresses interleukin-22 associated with bacterial infection in vitro and in vivo. Clin Exp Immunol 2009 0.88
90 Regulation and immunhistochemical localization of nitric oxide synthases and soluble guanylyl cyclase in mouse spinal cord following nociceptive stimulation. Neurosci Lett 2000 0.88
91 Role of cGMP as second messenger of adenosine in the inhibition of renin release. Kidney Int 1988 0.88
92 Non-hip, non-spine fractures drive healthcare utilization following a fracture: the Global Longitudinal Study of Osteoporosis in Women (GLOW). Osteoporos Int 2012 0.88
93 Glucocorticoids potently block tumour necrosis factor-alpha- and lipopolysaccharide-induced apoptotic cell death in bovine glomerular endothelial cells upstream of caspase 3 activation. Br J Pharmacol 1999 0.87
94 Cross-talk between secretory phospholipase A2 and cytosolic phospholipase A2 in rat renal mesangial cells. Biochim Biophys Acta 1997 0.87
95 5-Hydroxytryptamine 5-HT1B receptors inhibiting cyclic AMP accumulation in rat renal mesangial cells. Naunyn Schmiedebergs Arch Pharmacol 1995 0.87
96 Tetrahydrobiopterin is a limiting factor of nitric oxide generation in interleukin 1 beta-stimulated rat glomerular mesangial cells. Kidney Int 1994 0.87
97 Induction of inducible nitric oxide synthase and its corresponding tetrahydrobiopterin-cofactor-synthesizing enzyme GTP-cyclohydrolase I during cutaneous wound repair. J Invest Dermatol 1998 0.87
98 Inflammation-mediated osteopenia in the rat: a new animal model for pathological loss of bone mass. Endocrinology 1984 0.86
99 Identification of copper/zinc superoxide dismutase as a novel nitric oxide-regulated gene in rat glomerular mesangial cells and kidneys of endotoxemic rats. FASEB J 1999 0.86
100 Expression and release of chemokines associated with apoptotic cell death in human promonocytic U937 cells and peripheral blood mononuclear cells. Eur J Immunol 1999 0.86
101 Systemically and topically supplemented leptin fails to reconstitute a normal angiogenic response during skin repair in diabetic ob/ob mice. Diabetologia 2001 0.86
102 Dexamethasone differentially affects interleukin 1 beta- and cyclic AMP-induced nitric oxide synthase mRNA expression in renal mesangial cells. Biochem J 1994 0.86
103 Transforming growth factors type-beta and dexamethasone attenuate group II phospholipase A2 gene expression by interleukin-1 and forskolin in rat mesangial cells. FEBS Lett 1992 0.86
104 Nitric oxide and superoxide induced p53 and Bax accumulation during mesangial cell apoptosis. Kidney Int 1997 0.85
105 Potentiation of nitric oxide synthase expression by superoxide in interleukin 1 beta-stimulated rat mesangial cells. FEBS Lett 1998 0.85
106 PDGF suppresses the activation of group II phospholipase A2 gene expression by interleukin 1 and forskolin in mesangial cells. FEBS Lett 1991 0.85
107 'Antiflammins': two nonapeptide fragments of uteroglobin and lipocortin I have no phospholipase A2-inhibitory and anti-inflammatory activity. FEBS Lett 1990 0.85
108 Cytokine- and forskolin-induced synthesis of group II phospholipase A2 and prostaglandin E2 in rat mesangial cells is prevented by dexamethasone. Biochem Biophys Res Commun 1991 0.85
109 Apoptosis is triggered by the cyclic AMP signalling pathway in renal mesangial cells. FEBS Lett 1996 0.85
110 NaCl transport stimulates prostaglandin release in cultured renal epithelial (MDCK) cells. Am J Physiol 1986 0.84
111 Rapid and delayed p42/p44 mitogen-activated protein kinase activation by nitric oxide: the role of cyclic GMP and tyrosine phosphatase inhibition. J Immunol 1998 0.84
112 Interleukin-1 beta-induced cytosolic phospholipase A2 activity and protein synthesis is blocked by dexamethasone in rat mesangial cells. FEBS Lett 1993 0.84
113 FTY720 suppresses interleukin-1beta-induced secretory phospholipase A2 expression in renal mesangial cells by a transcriptional mechanism. Br J Pharmacol 2007 0.84
114 Interleukin 1 beta-induced expression of nitric oxide synthase in rat renal mesangial cells is suppressed by cyclosporin A. Biochem Biophys Res Commun 1995 0.84
115 Interferon-gamma induces expression of interleukin-18 binding protein in fibroblast-like synoviocytes. Rheumatology (Oxford) 2003 0.84
116 Effect of cyclic AMP and prostaglandin E2 on the induction of nitric oxide- and prostanoid-forming pathways in cultured rat mesangial cells. Biochem J 1996 0.84
117 Basic fibroblast growth factor selectively enhances TNF-alpha-induced apoptotic cell death in glomerular endothelial cells: effects on apoptotic signaling pathways. J Am Soc Nephrol 2000 0.84
118 Interleukin 1 beta and cAMP trigger the expression of GTP cyclohydrolase I in rat renal mesangial cells. Biochem J 1996 0.83
119 Possible role of protein kinase C-epsilon isoenzyme in inhibition of interleukin 1 beta induction of nitric oxide synthase in rat renal mesangial cells. Biochem J 1994 0.83
120 Pyrrolidine dithiocarbamate differentially affects cytokine- and cAMP-induced expression of group II phospholipase A2 in rat renal mesangial cells. FEBS Lett 1995 0.83
121 Role of prostaglandins in hypoxia-stimulated erythropoietin production. Am J Physiol 1985 0.83
122 Severe osteoporosis in familial Hajdu-Cheney syndrome: progression of acro-osteolysis and osteoporosis during long-term follow-up. J Bone Miner Res 1999 0.83
123 Characterization of group X phospholipase A(2) as the major enzyme secreted by human keratinocytes and its regulation by the phorbol ester TPA. J Invest Dermatol 2001 0.83
124 Low serum concentrations of insulin-like growth factor I are associated with femoral bone loss in a population-based sample of postmenopausal women. Clin Endocrinol (Oxf) 2001 0.83
125 Platelet-derived growth factor and fibroblast growth factor differentially regulate interleukin 1beta- and cAMP-induced nitric oxide synthase expression in rat renal mesangial cells. J Clin Invest 1997 0.83
126 Suppression of apoptosis by glucocorticoids in glomerular endothelial cells: effects on proapoptotic pathways. Br J Pharmacol 2000 0.82
127 Downregulation of iNOS expression in rat mesangial cells by special extracts of Harpagophytum procumbens derives from harpagoside-dependent and independent effects. Phytomedicine 2004 0.82
128 Serum parathyroid hormone, but not menopausal status, is associated with the expression of osteoprotegerin and RANKL mRNA in human bone samples. Eur J Endocrinol 2001 0.82
129 Keratinocyte-derived chemotactic cytokines: expressional modulation by nitric oxide in vitro and during cutaneous wound repair in vivo. Biochem Biophys Res Commun 2000 0.82
130 Cross-talk between group IIA-phospholipase A2 and inducible NO-synthase in rat renal mesangial cells. Br J Pharmacol 1999 0.82
131 Modulation of cytokine-induced expression of secretory phospholipase A2-type IIA by protein kinase C in rat renal mesangial cells. Biochem Pharmacol 1999 0.82
132 Cellular mechanisms of bradykinin-induced hyperpolarization in renal epitheloid MDCK-cells. Biochim Biophys Acta 1991 0.82
133 Transforming growth factor beta 2 stimulates acute and chronic activation of the mitogen-activated protein kinase cascade in rat renal mesangial cells. FEBS Lett 1994 0.81
134 Nitric oxide augments release of chemokines from monocytic U937 cells: modulation by anti-inflammatory pathways. Free Radic Biol Med 2000 0.81
135 Potentiation of cytokine induction of group IIA phospholipase A(2) in rat mesangial cells by ATP and adenosine via the A2A adenosine receptor. Br J Pharmacol 2001 0.81
136 Negative regulation of interleukin-1beta-activated neutral sphingomyelinase by protein kinase C in rat mesangial cells. FEBS Lett 1998 0.81
137 Transforming growth factor-beta 2 inhibits interleukin 1 beta-induced expression of inducible nitric oxide synthase in rat renal mesangial cells. Inflamm Res 1997 0.81
138 Regulation of inhibitor of apoptosis expression by nitric oxide and cytokines: relation to apoptosis induction in rat mesangial cells and raw 264.7 macrophages. J Am Soc Nephrol 2001 0.80
139 Suppression by cyclosporin A of interleukin 1 beta-induced expression of group II phospholipase A2 in rat renal mesangial cells. Br J Pharmacol 1997 0.80
140 Age-associated changes in the stimulatory effect of transforming growth factor beta on human osteogenic colony formation. Mech Ageing Dev 1999 0.80
141 Coordinated induction of inducible nitric oxide synthase and GTP-cyclohydrolase I is dependent on inflammatory cytokines and interferon-gamma in HaCaT keratinocytes: implications for the model of cutaneous wound repair. J Invest Dermatol 1998 0.80
142 Protein kinase C inhibitors potentiate angiotensin II-induced phosphoinositide hydrolysis and intracellular Ca2+ mobilization in renal mesangial cells. Eur J Pharmacol 1993 0.80
143 Comparison of different tumour promoters and bryostatin 1 on protein kinase C activation and down-regulation in rat renal mesangial cells. Biochem Pharmacol 1994 0.80
144 Feedback regulation of extracellular ATP-stimulated phosphoinositide hydrolysis by protein kinase C-alpha in bovine glomerular endothelial cells. Kidney Int 1997 0.80
145 Interleukin-1 stimulates de novo synthesis of mitogen-activated protein kinase in glomerular mesangial cells. FEBS Lett 1994 0.79
146 Parathyroid hormone inhibition of Na+/phosphate cotransport in OK cells: generation of second messengers in the regulatory cascade. Biochem Biophys Res Commun 1989 0.79
147 On the induction of cyclooxygenase-2, inducible nitric oxide synthase and soluble phospholipase A2 in rat mesangial cells by a nonsteroidal anti-inflammatory drug: the role of cyclic AMP. Mol Pharmacol 1998 0.79
148 Expression of Interleukin-6 (IL-6) and IL-6 receptor mRNA in human bone samples from pre- and postmenopausal women. Bone 2002 0.79
149 Effects of angiotensin II on bone cells in vitro. J Cell Physiol 1998 0.79
150 Parathyroid hormone inhibition of Na+/phosphate cotransport in OK cells: requirement of protein kinase C-dependent pathway. Biochim Biophys Acta 1989 0.79
151 Interleukin-1 beta and tumor necrosis factor-alpha synergistically stimulate nerve growth factor synthesis in rat mesangial cells. Am J Physiol 1991 0.79
152 Nitrosative and oxidative stress induced heme oxygenase-1 accumulation in rat mesangial cells. Eur J Pharmacol 1998 0.79
153 Role of wound macrophages in skin flap loss or survival in an experimental diabetes model. Br J Surg 2010 0.79
154 Effects of 6 years of growth hormone (GH) treatment on bone mineral density in GH-deficient adults. Clin Endocrinol (Oxf) 2001 0.79
155 Rat GTP cyclohydrolase I is a homodecameric protein complex containing high-affinity calcium-binding sites. J Mol Biol 1998 0.79
156 Differential recovery of protein kinase C-alpha and -epsilon isozymes after long-term phorbol ester treatment in rat renal mesangial cells. Biochem Biophys Res Commun 1991 0.79
157 Nitric oxide stimulates chronic ceramide formation in glomerular endothelial cells. Biochem Biophys Res Commun 1999 0.79
158 International management of bone health in glucocorticoid-exposed individuals in the observational GLOW study. Osteoporos Int 2014 0.79
159 Platelet-derived growth factor and fibroblast growth factor differentially regulate interleukin 1beta- and cAMP-induced group II phospholipase A2 expression in rat renal mesangial cells. Biochim Biophys Acta 1998 0.79
160 [Pharmacogenetics and pharmacogenomics of methotrexate. Current status and novel aspects]. Z Rheumatol 2011 0.79
161 Proteolytic cleavage of inducible nitric oxide synthase (iNOS) by calpain I. Biochim Biophys Acta 2001 0.78
162 Interleukin 1- and tumor necrosis factor-stimulation of prostaglandin E2 synthesis in MDCK cells, and potentiation of this effect by cycloheximide. FEBS Lett 1990 0.78
163 Regulation of interleukin-18 (IL-18) expression in keratinocytes (HaCaT): implications for early wound healing. Eur Cytokine Netw 2000 0.78
164 Concentration of insulin-like growth factor (IGF)-I in iliac crest bone matrix in premenopausal women with idiopathic osteoporosis. Exp Clin Endocrinol Diabetes 2004 0.78
165 Inhibition of NFkappaB-mediated pro-inflammatory gene expression in rat mesangial cells by the enolized 1,3-dioxane-4, 6-dione-5-carboxamide, CGP-43182. Br J Pharmacol 2000 0.78
166 Enhanced expression of group IIA secreted phospholipase A2 by elevated glucose levels in cytokine-stimulated rat mesangial cells and in kidneys of diabetic rats. Clin Nephrol 2005 0.78
167 Downregulation of integrin-linked kinase mRNA expression by nitric oxide in rat glomerular mesangial cells. Life Sci 2001 0.78
168 Thiazolidinedione-dependent activation of sphingosine kinase 1 causes an anti-fibrotic effect in renal mesangial cells. Br J Pharmacol 2012 0.78
169 Nitric oxide and vascular remodeling: spotlight on the kidney. Kidney Int Suppl 2007 0.78
170 Pharmacological properties of five diclofenac metabolites identified in human plasma. Agents Actions 1991 0.78
171 Effects of triiodothyronine on the insulin-like growth factor system in primary human osteoblastic cells in vitro. Bone 2001 0.77
172 Modulatory role of platelet-derived growth factor on cytokine-induced nerve growth factor synthesis in rat glomerular mesangial cells. Biochem J 1995 0.77
173 Inhibition of erythropoietin production by phorbol ester is associated with down-regulation of protein kinase C-alpha isoenzyme in hepatoma cells. Biochem Biophys Res Commun 1991 0.77
174 Angiotensin II stimulation of the stress-activated protein kinases in renal mesangial cells is mediated by the angiotensin AT1 receptor subtype. Eur J Pharmacol 1998 0.77
175 Effect of synthetic atrial natriuretic peptide on rat renal juxtaglomerular cells. J Hypertens Suppl 1986 0.77
176 Differential effect of dexamethasone on interleukin 1beta- and cyclic AMP-triggered expression of GTP cyclohydrolase I in rat renal mesangial cells. Br J Pharmacol 1997 0.77
177 Apoptosis and expression of inducible nitric oxide synthase are mutually exclusive in renal mesangial cells. Am J Pathol 1997 0.77
178 [Osteoporosis diagnosis and therapy according to the 2010 guidelines]. Z Rheumatol 2010 0.77
179 Positive association between circulating free thyroxine and insulin-like growth factor l concentrations in euthyroid elderly individuals. Clin Endocrinol (Oxf) 1998 0.77
180 Effects of dexamethasone and transforming growth factor-beta 2 on group II phospholipase A2 mRNA and activity levels in interleukin 1 beta- and forskolin-stimulated mesangial cells. Biochem J 1996 0.77
181 Downregulation of SPARC expression is mediated by nitric oxide in rat mesangial cells and during endotoxemia in the rat. J Am Soc Nephrol 2000 0.77
182 Age-related changes in insulin-like growth factor I and II in human femoral cortical bone: lack of correlation with bone mass. Bone 1999 0.77
183 Inhibition of renin secretion by platelet activating factor (acetylglyceryl ether phosphorylcholine) in cultured rat renal juxtaglomerular cells. Biochem Biophys Res Commun 1985 0.77
184 [Prevalence of thyroid gland dysfunctions in 50- to 80-year-old patients. An epidemiologic cross-sectional study in a southwestern community]. Med Klin (Munich) 1997 0.77
185 Light evoked inositol trisphosphate release in the rat retina in vitro. Curr Eye Res 1993 0.77
186 Superoxide potently induces ceramide formation in glomerular endothelial cells. Biochem Biophys Res Commun 2001 0.77
187 Leptin concentrations in serum from a randomly recruited sample of 50- to 80-year-old men and women: positive association with plasma insulin-like growth factors (IGFs) and IGF-binding protein-3 in lean, but not in obese, individuals. Eur J Endocrinol 1998 0.76
188 Mechanism of NaCl transport-stimulated prostaglandin formation in MDCK cells. Am J Physiol 1987 0.76
189 Protein kinase C in the rat retina: immunocharacterization of calcium-independent delta, epsilon and zeta isoenzymes. Brain Res Mol Brain Res 1992 0.76
190 Bone matrix insulin-like growth factor (IGF)-I, IGF-II and transforming growth factor (TGF)-beta1 levels in men and postmenopausal women with osteoporosis: lack of association with circulating growth factors and bone mineral density. Rev Med Chir Soc Med Nat Iasi 2005 0.76
191 Tetranactin inhibits interleukin 1 beta and cAMP induction of group II phospholipase A2 in rat renal mesangial cells. Eur J Pharmacol 1996 0.76
192 Patterns of hormone replacement therapy in a population-based cohort of postmenopausal German women. Changes after HERS II and WHI. Exp Clin Endocrinol Diabetes 2005 0.76
193 Parathyroid hormone inhibition of Na+/phosphate cotransport in OK cells: intracellular [Ca2+] as a second messenger. Biochim Biophys Acta 1989 0.76
194 Platelet-derived growth factor stimulates de-novo synthesis of mitogen-activated protein kinase in renal mesangial cells. Eur J Biochem 1995 0.76
195 [Evidence-based clinical practice guidelines for diagnosis and treatment of osteoporosis]. Dtsch Med Wochenschr 2003 0.75
196 Inhibition by tetranactin of interleukin 1 beta- and cyclic AMP-induced nitric oxide synthase expression in rat renal mesangial cells. Br J Pharmacol 1996 0.75
197 Assessment of sex hormone-binding globulin and osteocalcin in patients undergoing coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth 2000 0.75
198 [Pretherapeutic metastases diagnosis in bronchial cancer with special reference to nuclear medicine procedures]. Schweiz Med Wochenschr 1981 0.75
199 The pharmacological profile of CGP 28238, a novel highly potent anti-inflammatory compound. Drugs Exp Clin Res 1989 0.75
200 Influence of fluor salts, hormone replacement therapy and calcitonin on the concentration of insulin-like growth factor (IGF)-I, IGF-II and transforming growth factor-beta 1 in human iliac crest bone matrix from patients with primary osteoporosis. Eur J Endocrinol 2004 0.75
201 The induction of cellular group II phospholipase A2 by cytokines and its prevention by dexamethasone. Adv Exp Med Biol 1992 0.75
202 Effect of cell density on growth regulation of human glomerular epithelial cells. Inhibition of growth by dbcAMP and cAMP-elevating agonists. Cell Signal 1991 0.75
203 Amplification of nitric oxide synthase expression by nitric oxide in interleukin 1beta-stimulated rat mesangial cells. Adv Exp Med Biol 1996 0.75
204 Erythropoietin production in cultures of rat renal mesangial cells. Contrib Nephrol 1986 0.75
205 Distinct signaling pathways mediate phorbol-ester-induced and cytokine-induced inhibition of erythropoietin gene expression. Eur J Biochem 1994 0.75
206 Simultaneous registration of Ca(2+) transients and volume changes in rat mesangial cells: Evaluation of the effects of protein kinase C down-regulation. J Fluoresc 1992 0.75
207 Hypoxia enhances prostaglandin synthesis in renal mesangial cell cultures. Prostaglandins 1985 0.75
208 [Current interdisciplinary diagnosis and therapy of endocrine orbitopathy. Smoking and endocrine orbitopathy]. Dtsch Med Wochenschr 1997 0.75
209 [Osteoporosis--which therapy is confirmed?]. Internist (Berl) 2009 0.75
210 Inflammation-mediated osteopenia in the rat: the effects of artificial granuloma and sham operation on cortical and trabecular bone. Bone 1985 0.75
211 Angiotensin II binding sites on micro-organisms contaminating cell cultures. Regul Pept 1993 0.75
212 Cyclosporin A inhibits PGE2 release from vascular smooth muscle cells. Biochem Biophys Res Commun 1987 0.75
213 The glomerular cell: source and target of various mediators. Kidney Int Suppl 1997 0.75
214 Tumor necrosis factor alpha inhibits the stimulatory effect of the parathyroid hormone-related protein on cyclic AMP formation in osteoblast-like cells via protein kinase C+. Biochem Biophys Res Commun 1992 0.75
215 [Lithium-induced lesions in the rat retina--potentiation by light]. Klin Monbl Augenheilkd 1988 0.75
216 Effects of estrogen on the concentration of insulin-like growth factor-I in rat bone matrix. Bone 1998 0.75
217 Translocation of protein kinase C isoenzymes by elevated extracellular Ca2+ concentration in cells from a human giant cell tumor of bone. Bone 1995 0.75
218 [Osteoporosis: prophylaxis, diagnostics and therapy according to the guidelines]. Internist (Berl) 2011 0.75
219 The effects of triiodothyronine on human osteoblast-like cells metabolism and interactions with growth hormone. Exp Clin Endocrinol Diabetes 2003 0.75
220 Effect of glucocorticoid-, parathyroid- and thyroid hormones excess on human iliac crest bone matrix insulin-like growth factor (IGF)-I in patients with osteoporosis. Exp Clin Endocrinol Diabetes 2009 0.75
221 A role for protein kinase C-alpha in zymosan-stimulated eicosanoid synthesis in mouse peritoneal macrophages. Eur J Biochem 1993 0.75
222 Potentiation by light of lithium-induced retinal injury in rats. N Engl J Med 1987 0.75